Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000520498 | SCV000619998 | uncertain significance | not provided | 2017-08-15 | criteria provided, single submitter | clinical testing | The c.928_930delATC variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.928_930delATC variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The c.928_930delATC variant results in an in-frame deletion of a single Isoleucine residue, denoted p.Ile310del. This substitution occurs at a position where amino acids with similar properties to Isoleucine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. However, other in-frame deletions have not been reported in the Human Gene Mutation Database in association with RELN-related disorders (Stenson et al., 2014). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Revvity Omics, |
RCV003129883 | SCV003813826 | uncertain significance | Norman-Roberts syndrome | 2021-12-29 | criteria provided, single submitter | clinical testing |